Achillion Pharmaceuticals Inc (ACHN.O)

ACHN.O on Nasdaq

7.03USD
1 Aug 2013
Price Change (% chg)

$-0.11 (-1.54%)
Prev Close
$7.14
Open
$7.20
Day's High
$7.21
Day's Low
$7.00
Volume
675,151
Avg. Vol
1,288,063
52-wk High
$11.36
52-wk Low
$5.42

ACHN.O

Chart for ACHN.O

About

Achillion Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases. The Company is engaged in the development of antivirals for the treatment of chronic hepatitis C infection (HCV), and the development of antibacterials for the... (more)

Overall

Beta: 0.59
Market Cap (Mil.): $689.41
Shares Outstanding (Mil.): 96.56
Dividend: --
Yield (%): --

Financials

  ACHN.O Industry Sector
P/E (TTM): -- 47.13 37.76
EPS (TTM): -0.64 -- --
ROI: -38.28 -2.58 18.76
ROE: -38.40 -2.66 19.59
Search Stocks

UPDATE 1-FDA places clinical hold on Achillion's hep C drug, shares plunge

* Co says liver enzymes elevated in drug interaction with HIV drug

01 Jul 2013

FDA places clinical hold on Achillion's hepatitis C drug

July 1 - Achillion Pharmaceuticals Inc said the U.S. Food and Drug Administration had placed a clinical hold on its hepatitis C drug sovaprevir after elevations in liver enzymes were noted in an early-stage study of the drug's interaction with an HIV drug.

01 Jul 2013

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Wright Reports
$460.00
Provider: S&P Capital IQ Quantitative Report
$69.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks